The second half of 2024 began on a strong note in Helsinki, with the stock exchange’s general index rising by about 1.1 percent to 10,050.26 points in the afternoon. The most exchanged share was Nordea, up by 1.6 percent with nearly 20 million shares exchanged.
In terms of gains, technology consulting company Solteq saw the biggest increase with a 10.1 percent rise. Meanwhile, biotechnology company Nightingale Health experienced a decline of 9.1 percent.
Several major companies made announcements during this period as well. IT service company Tietoevry extended its strategic evaluation and sale of the Tech Services business, with more information to be provided by the time of the third quarter results report on October 24. Kemira signed a contract to acquire the reactivation business in Great Britain from Purton Carbons Limited, marking its first step into the activated carbon market.
Lemonsoft announced it would purchase software developer Applirentin in a deal worth approximately EUR 2.3 million. Herantis Pharma received funding for a phase 1b clinical trial from the Michael J. Fox Foundation for Parkinson’s Research. Telko, a subsidiary of Aspo, completed the acquisition of Swed Handling AB in Sweden.
Cargotec split from Kalmar, becoming its own listed company on the stock exchange’s main list
